期刊
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
卷 10, 期 9, 页码 926-929出版社
OXFORD UNIV PRESS
DOI: 10.1093/jpids/piab029
关键词
bradycardia; COVID-19; pediatrics; remdesivir; SARS-CoV-2
资金
- National Institute of Allergy and Infectious Diseases [K08AI150996-01]
This article describes a case of sinus bradycardia associated with Remdesivir therapy in a pediatric patient with severe COVID-19.
Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with severe acute COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据